Suppr超能文献

趋化因子受体命名法中的一个非典型补充:IUPHAR综述15。

An atypical addition to the chemokine receptor nomenclature: IUPHAR Review 15.

作者信息

Bachelerie Françoise, Graham Gerard J, Locati Massimo, Mantovani Alberto, Murphy Philip M, Nibbs Robert, Rot Antal, Sozzani Silvano, Thelen Marcus

机构信息

INSERM UMR-S996, Laboratory of Excellence in Research on Medication and Innovative Therapeutics, Université Paris-Sud, Clamart, France.

Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, UK.

出版信息

Br J Pharmacol. 2015 Aug;172(16):3945-9. doi: 10.1111/bph.13182. Epub 2015 Jun 26.

Abstract

Chemokines and their receptors are essential regulators of in vivo leukocyte migration and, some years ago, a systematic nomenclature system was developed for the chemokine receptor family. Chemokine receptor biology and biochemistry was recently extensively reviewed. In this review, we also highlighted a new component to the nomenclature system that incorporates receptors previously known as 'scavenging', or 'decoy', chemokine receptors on the basis of their lack of classical signalling responses to ligand binding and their general ability to scavenge, or sequester, their cognate chemokine ligands. These molecules are now collectively referred to as 'atypical chemokine receptors', or ACKRs, and play fundamental roles in regulating in vivo responses to chemokines. This commentary highlights this new addition to the chemokine receptor nomenclature system and provides brief information on the four receptors currently covered by this nomenclature.

摘要

趋化因子及其受体是体内白细胞迁移的重要调节因子,几年前,趋化因子受体家族建立了一个系统的命名体系。最近,有关趋化因子受体生物学和生物化学的内容已有广泛综述。在本综述中,我们还强调了命名体系中的一个新成员,该成员纳入了以前被称为“清除性”或“诱饵”趋化因子受体的分子,这些受体基于其对配体结合缺乏经典信号反应以及清除或隔离其同源趋化因子配体的一般能力。这些分子现在统称为“非典型趋化因子受体”(ACKRs),在调节体内对趋化因子的反应中发挥着重要作用。本述评突出了趋化因子受体命名体系中的这一新增内容,并简要介绍了目前该命名体系涵盖的四种受体。

相似文献

7
Atypical chemokine receptors in the immune system.免疫系统中的非典型趋化因子受体
Nat Rev Immunol. 2024 Oct;24(10):753-769. doi: 10.1038/s41577-024-01025-5. Epub 2024 May 7.
8
Chemokine/chemokine receptor nomenclature.趋化因子/趋化因子受体命名法。
Cytokine. 2003 Jan 7;21(1):48-9. doi: 10.1016/s1043-4666(02)00493-3.

引用本文的文献

4
Atypical chemokine receptors in the immune system.免疫系统中的非典型趋化因子受体
Nat Rev Immunol. 2024 Oct;24(10):753-769. doi: 10.1038/s41577-024-01025-5. Epub 2024 May 7.
5
The Role of CCL3 in the Pathogenesis of Rheumatoid Arthritis.CCL3在类风湿关节炎发病机制中的作用
Rheumatol Ther. 2023 Aug;10(4):793-808. doi: 10.1007/s40744-023-00554-0. Epub 2023 May 25.

本文引用的文献

3
Bias in chemokine receptor signalling.趋化因子受体信号转导中的偏倚。
Trends Immunol. 2014 Jun;35(6):243-52. doi: 10.1016/j.it.2014.02.004. Epub 2014 Mar 26.
10
CXCR7 impact on CXCL12 biology and disease.CXCR7 对 CXCL12 生物学和疾病的影响。
Trends Mol Med. 2013 Jan;19(1):12-22. doi: 10.1016/j.molmed.2012.10.004. Epub 2012 Nov 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验